Gene: AHCYL1
Official Full Name: adenosylhomocysteinase like 1provided by HGNC
Gene Summary: The protein encoded by this gene interacts with inositol 1,4,5-trisphosphate receptor, type 1 and may be involved in the conversion of S-adenosyl-L-homocysteine to L-homocysteine and adenosine. Several transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jun 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31551 | AHCYL1 Knockout cell line (HeLa) | Human | AHCYL1 | 1:3~1:6 | Negative | Online Inquiry |
KO31552 | AHCYL1 Knockout cell line (HCT 116) | Human | AHCYL1 | 1:2~1:4 | Negative | Online Inquiry |
KO31553 | AHCYL1 Knockout cell line (HEK293) | Human | AHCYL1 | 1:3~1:6 | Negative | Online Inquiry |
KO31554 | AHCYL1 Knockout cell line (A549) | Human | AHCYL1 | 1:3~1:4 | Negative | Online Inquiry |
AHCYL1 Gene Knockout Cell Lines are specialized cellular models that have been created to lack expression of the AHCYL1 gene, which encodes for the enzyme AdoHcy hydrolase. This enzyme plays a critical role in the methylation cycle by regulating the levels of S-adenosylhomocysteine (AdoHcy), a potent inhibitor of S-adenosylmethionine (AdoMet)-dependent methyltransferases. The knockout of AHCYL1 leads to a significant increase in AdoHcy levels, providing researchers with a unique tool to study the intricate processes of cellular methylation and associated signaling pathways.
These cell lines facilitate investigations into the biological effects of disrupted methylation patterns, which are implicated in various diseases, including cancer and neurodegenerative disorders. By leveraging these knockout models, researchers can elucidate the mechanistic connections between AHCYL1 activity, cellular metabolism, and therapeutic responses. This product serves a vital role in advancing our understanding of cellular bioenergetics and gene regulation, making it indispensable for both basic research and drug discovery applications.
One of the standout advantages of AHCYL1 Gene Knockout Cell Lines is their specificity and reproducibility. Compared to traditional RNA interference or chemical inhibition methods, gene knockout provides a more permanent and consistent model for functional studies. This is crucial for investigators seeking to derive reliable data for hypothesis-driven research or therapeutic development. Furthermore, these cell lines can be easily integrated into high-throughput screening assays for candidate drug evaluation.
For researchers, clinicians, and biotechnologists striving to innovate in areas of metabolic regulation and gene therapy, AHCYL1 Gene Knockout Cell Lines present a significant value proposition. With a clear focus on advancing scientific understanding and developing effective therapeutic strategies, our company is dedicated to providing high-quality, genetically engineered resources tailored to the evolving needs of the research community. As experts in the field of biological products, we are committed to support your research objectives with precision-engineered solutions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.